[Clonidine in the treatment of cancer pain]

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

[Clonidine in the treatment of cancer pain]. / Nielsen, Jonas Bøje; Sjøgren, Per.

In: Ugeskrift for læger, Vol. 170, No. 45, 2008, p. 3650-3653.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Nielsen, JB & Sjøgren, P 2008, '[Clonidine in the treatment of cancer pain]', Ugeskrift for læger, vol. 170, no. 45, pp. 3650-3653.

APA

Nielsen, J. B., & Sjøgren, P. (2008). [Clonidine in the treatment of cancer pain]. Ugeskrift for læger, 170(45), 3650-3653.

Vancouver

Nielsen JB, Sjøgren P. [Clonidine in the treatment of cancer pain]. Ugeskrift for læger. 2008;170(45):3650-3653.

Author

Nielsen, Jonas Bøje ; Sjøgren, Per. / [Clonidine in the treatment of cancer pain]. In: Ugeskrift for læger. 2008 ; Vol. 170, No. 45. pp. 3650-3653.

Bibtex

@article{59c3b51005d311deb05e000ea68e967b,
title = "[Clonidine in the treatment of cancer pain]",
abstract = "Clonidine is an alpha2-adrenergic agonist with analgetic properties. Due to its side-effects, the drug is administered via the epidural or spinal route. A literature search yielded nine controlled studies on clonidine as a supplemental drug in the epidural or spinal treatment of cancer pain. These studies were systematically reviewed to evaluate the evidence of efficacy in patients with cancer pain. CONCLUSION: Despite weak evidence, clonidine may be a useful adjunct in epidural or spinal morphine therapy of cancer pain Udgivelsesdato: 2008/11/3",
author = "Nielsen, {Jonas B{\o}je} and Per Sj{\o}gren",
year = "2008",
language = "Dansk",
volume = "170",
pages = "3650--3653",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "45",

}

RIS

TY - JOUR

T1 - [Clonidine in the treatment of cancer pain]

AU - Nielsen, Jonas Bøje

AU - Sjøgren, Per

PY - 2008

Y1 - 2008

N2 - Clonidine is an alpha2-adrenergic agonist with analgetic properties. Due to its side-effects, the drug is administered via the epidural or spinal route. A literature search yielded nine controlled studies on clonidine as a supplemental drug in the epidural or spinal treatment of cancer pain. These studies were systematically reviewed to evaluate the evidence of efficacy in patients with cancer pain. CONCLUSION: Despite weak evidence, clonidine may be a useful adjunct in epidural or spinal morphine therapy of cancer pain Udgivelsesdato: 2008/11/3

AB - Clonidine is an alpha2-adrenergic agonist with analgetic properties. Due to its side-effects, the drug is administered via the epidural or spinal route. A literature search yielded nine controlled studies on clonidine as a supplemental drug in the epidural or spinal treatment of cancer pain. These studies were systematically reviewed to evaluate the evidence of efficacy in patients with cancer pain. CONCLUSION: Despite weak evidence, clonidine may be a useful adjunct in epidural or spinal morphine therapy of cancer pain Udgivelsesdato: 2008/11/3

M3 - Tidsskriftartikel

VL - 170

SP - 3650

EP - 3653

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 45

ER -

ID: 10927908